Propagenix
Gaithersburg, US · Founded 2013 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
BP
Brian PollokExecutive
SC
Sharon ChallbergExecutive
Board
DR
David RossBoard director
GB
Greg BettertonBoard director
WK
Wlodek KrawiecBoard director
JK
John KontorBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$6.5M disclosed across 1 round · 2016
▶$6.5MraisedMar 2016 · 2 investors · BiotechnologyRule 506(b)
▶$6.5MraisedMar 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David RossDirector
- Brian PollokExecutive Officer, Director
- Sharon ChallbergExecutive Officer
- Greg BettertonDirector
- Wlodek KrawiecDirector
- John KontorDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Propagenix's investors?
- Propagenix's investors include Maryland TEDCO, TEDCO.
- How much funding has Propagenix raised?
- Propagenix has disclosed $6.5M raised across 1 round.
- Where is Propagenix headquartered?
- Propagenix is headquartered in Gaithersburg, US.